Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Return on Equity (2016 - 2025)

Wave Life Sciences' Return on Equity history spans 11 years, with the latest figure at 0.64% for Q4 2025.

  • For Q4 2025, Return on Equity fell 8.0% year-over-year to 0.64%; the TTM value through Dec 2025 reached 0.64%, down 8.0%, while the annual FY2025 figure was 0.56%, 22.0% up from the prior year.
  • Return on Equity reached 0.64% in Q4 2025 per WVE's latest filing, up from 0.92% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 134.32% in Q4 2023 to a low of 11.57% in Q3 2022.
  • Average Return on Equity over 5 years is 4.72%, with a median of 1.41% recorded in 2024.
  • Peak YoY movement for Return on Equity: surged 12780bps in 2023, then crashed -13487bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 3.92% in 2021, then soared by 267bps to 6.52% in 2022, then surged by 1959bps to 134.32% in 2023, then plummeted by -100bps to 0.55% in 2024, then fell by -15bps to 0.64% in 2025.
  • Per Business Quant, the three most recent readings for WVE's Return on Equity are 0.64% (Q4 2025), 0.92% (Q3 2025), and 0.84% (Q2 2025).